NOVONIX to Commence Trading on Nasdaq through Level II ADR Program

Rhea-AI Summary

NOVONIX Limited (ASX: NVX, NASDAQ: NVX, OTCQX: NVNXF) has announced that its American Depositary Receipts (ADRs) will begin trading on Nasdaq today. The U.S. Securities and Exchange Commission has declared its registration statements effective. Each ADR represents four fully paid shares of NOVONIX and aims to broaden the company's investor base in the U.S. while providing shareholders similar rights to dividends and voting as ordinary shareholders. This move is part of NOVONIX's strategy to enhance its presence in the North American market.

Positive

• NOVONIX's ADRs will trade on Nasdaq, increasing accessibility for U.S. investors.
• Each ADR represents four shares, potentially boosting interest among institutional investors.
• The initiative aligns with NOVONIX's strategy to expand its U.S. investor base.

Negative

• None.

BRISBANE, Australia--(BUSINESS WIRE)-- NOVONIX Limited (ASX: NVX, NASDAQ: NVX, OTCQX: NVNXF) (“NOVONIX” or “the Company”), announces that its American Depositary Receipts ("ADRs") will commence trading on the Nasdaq Stock Market (‘Nasdaq’) today and its registration statements on Form 20-F and F-6 have been declared effective by the U.S. Securities and Exchange Commission. The Bank of New York Mellon has been appointed depositary, custodian and registrar for the Level II ADR program.

NOVONIX’s ADRs will trade on Nasdaq under the ticker symbol “NVX” and will complement the existing primary listing of NVX shares on the Australian Securities Exchange ("ASX"). Under the Level II program, the ADRs are based on NOVONIX’s ordinary shares currently on issue. Each ADR represents four (4) fully paid shares of NOVONIX.

An ADR is a negotiable receipt, resembling a stock certificate that is issued by a United States depositary bank appointed to evidence one or more American Depositary Shares. Establishing this program is part of an ongoing strategy to expand NOVONIX’s reach to investors in the United States and make the Company’s securities eligible as a direct investment for North American institutions and fund managers.

Under the program, the owners and holders of ADRs will have the same rights to dividends and distributions and voting powers as the holders of NOVONIX’s ordinary shares (ASX: NVX) and F shares (OTCQX: NVNXF), subject to the terms of the deposit agreement.

The establishment of the program by NOVONIX is not a public offering or issuance of new NOVONIX ordinary shares. For more information about the ADR program, including instructions for converting ordinary shares (ASX: NVX) and F shares NOVONIX (OTCQX: NVNXF) to ADRs can be found on the Company’s investor relations website at https://ir.novonixgroup.com.

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the U.S. Securities Act of 1933, as amended ("Securities Act"). This announcement is being issued in accordance with Rule 135 under the Securities Act.

This announcement has been authorised for release by NOVONIX Chairman, Admiral Robert J. Natter, USN Ret.

About NOVONIX

NOVONIX Limited (ASX: NVX, NASDAQ: NVX, OTCQX: NVNXF) is an integrated developer and supplier of high-performance materials, equipment and services for the global lithium-ion battery industry with operations in the U.S. and Canada and sales in more than 14 countries.

NOVONIX is a leading producer of synthetic graphite anode materials used in the making of lithium-ion batteries that power electric vehicles, personal electronics, medical devices and energy storage units. NOVONIX’s anode materials business is based in Chattanooga, Tennessee, where its goal is to increase capacity to produce 10,000 metric tons per year of synthetic graphite by 2023, with further targets of 40,000 tpa by 2025 and 150,000 tpa by 2030. NOVONIX, which has operations in the U.S. and Canada, is also a global supplier of advanced battery-testing services.

NOVONIX's mission is to enable a clean energy future by producing longer-life and lower-cost battery materials and technologies.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, including statements that relate to the company's plans for the U.S. Listing, the commencement of trading of the ADRs on the Nasdaq, and regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would,” or the negative of these words or other similar terms or expressions. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. These forward-looking statements are subject to a number of known and unknown risks, uncertainties, other factors and assumptions. We undertake no obligation to update any forward-looking statements made in this registration statement to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220131005966/en/

For NOVONIX Limited:

Stefan Norbom, ir@novonixgroup.com (investors)

Kiki O’Keeffe, media@novonixgroup.com (media)

Source: NOVONIX Limited

FAQ

When will NOVONIX's ADRs start trading on Nasdaq?

NOVONIX's ADRs commenced trading on Nasdaq today.

What does each NOVONIX ADR represent?

Each NOVONIX ADR represents four fully paid shares of NOVONIX.

How does the ADR program benefit NOVONIX shareholders?

ADRs provide shareholders with the same rights to dividends and voting as ordinary shares.

What is the ticker symbol for NOVONIX's ADRs on Nasdaq?

The ticker symbol for NOVONIX's ADRs on Nasdaq is NVX.

Why is NOVONIX establishing an ADR program?

The ADR program aims to expand NOVONIX's reach to U.S. investors and facilitate direct investments.